Sign in

Research summary ·

Blood-activating and collateral-unblocking traditional Chinese medicine formulas combined with mecobalamin for peripheral neuropathy in type 2 diabetes: a systematic review and Bayesian network meta-analysis.

Written based on 1 research study on PubMed, searched on 5 Nov 2026.

What was studied

This review compared Chinese herbal formulas for diabetic peripheral neuropathy, or DPN. The formulas aim to improve blood flow and unblock collaterals. They were given with mecobalamin. The comparison was mecobalamin alone. Patients were adults with type 2 diabetes and nerve damage in the limbs. The team searched PubMed, Embase, CNKI and other databases up to July 2026. It used a Bayesian network meta-analysis. The main outcome was the Toronto Clinical Scoring System, or TCSS.

What they found

The review included 19 randomised trials with 2,090 participants. All were done in China. Most add-on regimens improved TCSS. Many also sped nerve conduction. For TCSS, 9 of 12 formulas had intervals that did not include zero. For median nerve MCV, 7 of 14 formulas did the same. Different formulas ranked top for different outcomes. Some trials said nothing on adverse-event monitoring. No trial gave numeric lab safety data.

What it means for patients

The authors say add-on formulas were linked to better TCSS and nerve conduction in DPN. They say certainty was very low for every comparison. They say the rankings are exploratory. They say the rankings cannot prove efficacy. They say the rankings cannot pick a formula for any patient.

Why it is not certain yet

The evidence was rated very low in certainty for each comparison. For some outcomes, the prediction intervals included no effect. A new study could flip the direction of effect. Most nodes rested on a lone trial. The available information is insufficient to judge safety.

Source

Blood-activating and collateral-unblocking traditional Chinese medicine formulas combined with mecobalamin for peripheral neuropathy in type 2 diabetes: a systematic review and Bayesian network meta-analysis.

PubMed · PMID 42818718

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Type 2 diabetes publications